Searched for
LATE STAGE COMPANIES
OpenAI joins rival Anthropic in race to Wall StreetOpenAI did not disclose the size or terms of the offering, and said a timeline has not yet been determined. "It may be a while because ther...- Data security firm Cyera raises $600 million at $12 billion valuationData security firm Cyera secured a significant funding round. The company raised 600 million dollars valuing it at 12 billion dollars. This...
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- OpenAI files for US IPO after Anthropic as AI giants head to public marketsAI giant OpenAI has confidentially filed for a US initial public offering. This move follows rival Anthropic's similar filing. Investors ar...
- India Quotient partner Gagan Goyal to quit as churn at top VC funds in India continuesGagan Goyal, a general partner at India Quotient, is leaving the early-stage venture capital firm, according to people aware of the matter....
- India's climate-tech funding reaches $12.8 billion across 1,583 startups & 17 yearsIndia's climate-tech sector has attracted significant investment, with startups raising $12.8 billion by June 2026. Driven by decarbonisati...
- Why is the US stock market rallying big today? Dow Jones, S&P 500 and Nasdaq surge on AI boom — Nvidia and Intel jump as Nasdaq significantly outperformed both the Dow and S&PUS Stock Market Rallies Monday as Tech Leads Rebound After Friday's Selloff: The Dow Jones Industrial Average climbed above 51,000. The S&P...
- Tech stocks dive as Fed bets rattle AI rallyAsian markets are experiencing a significant downturn. High-flying semiconductor stocks are bearing the brunt of the selloff. This follows ...
- Two Trades for Today: A defence electronics player for an 8.35% rise, a mid-cap transmission equipment stock for a 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- ‘Main Street vs The Merger’: Hollywood workers rally against $110 bn Paramount-Warner dealA major media merger faces opposition from industry professionals and politicians. They fear the Paramount Skydance acquisition of Warner B...
- How Larry Ellison, Masayoshi Son, Michael Saylor AI crypto billionaires reshaping legacy wealth in 2026 markets shift?Oracle’s AI cloud surge, SoftBank’s OpenAI-backed rebound, and MicroStrategy’s Bitcoin strategy reflect a new billionaire era. Over $1 tril...
- Novo Holdings commits 500 million euros in new European tech growth fundNovo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...
- AI companies are barreling toward huge Wall Street debuts. A look at the biggest playersFrom Anthropic to SpaceX to OpenAI, tech giants are looking to take their shares public to access more capital in the race to shape the tec...
- Unilever says it won't miss India's premium boom like it did in ChinaUnilever CEO Fernando Fernandez stated the company will not repeat past mistakes in China by being late to India's premium market. He empha...
- South Korea, Taiwan leapfrog India, but the race was lost decades agoSouth Korea and Taiwan have surged ahead of India in global stock markets, driven by AI-powered semiconductor booms. Their success stems fr...
- Anthropic IPO filing ratifies Wall Street's AI obsessionTech stocks continue to lead the Nasdaq Composite and S&P 500 in a record-breaking market rally, while Elon Musk's SpaceX is set to price i...
- Investment platform LVX launches Elvix, an AI tool for private market investorsLVX Ventures has launched Elvix, an AI platform offering continuous investment feedback. Built on extensive private market data, Elvix help...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- ETtech Deals Digest: Startups raised $1.11 billion in May, up 37% on-yearIndian startups secured approximately $1.1 billion in May, a significant 37% year-over-year increase, driven by Rapido's substantial $240 m...
Load More
